Skip to content

Impact of Exercise on the Metabolic Consequences of Overeating

Impact of Exercise on the Metabolic Consequences of Overeating

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02701738
Acronym
XO
Enrollment
60
Registered
2016-03-08
Start date
2016-01-12
Completion date
2017-12-08
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The primary purpose of this study is to examine the effects of 1-week of overeating on important clinical metabolic health outcomes (e.g., glucose tolerance, blood lipid profile, and blood pressure) and factors regulating the structure and metabolic function of fat tissue. This study will determine how regular exercise during this overeating period impacts these responses.

Detailed description

If subjects are eligible and decide to participate, they will take part in two identical study trials. One is scheduled before and the other is scheduled after 1 week of overeating controlled by the study team. Subjects who exercise regularly will be instructed to exercise the day before their first study trial - and they will be required to exercise during 6 of the 7 days of the overeating period (including the day before their second study trial). Subjects who do not regularly exercise (no planned physical activity) will remain inactive until the completion of both study trials. Before each study trial If a subject is a regular exerciser, they will be asked to come to the Substrate Metabolism Laboratory in the afternoon before each of the 2 study trials to exercise in the lab for 45 min at a moderate intensity. The evening before the study trial, all subjects will need to eat a standardized dinner meal and snack. They must eat the meal and snack at specific times as indicated by the research staff. After eating the snack, subjects will need to fast (no food or beverages - besides water) overnight. During each study trial Subjects will arrive at the Substrate Metabolism Laboratory at 7:00AM and will rest quietly for approximately 30 min. After which, the study team will measure their resting blood pressure and their resting metabolic rate. An intravenous catheter (IV) will then be placed in a vein of the subject's hand or forearm for blood sampling. The research team will then collect a small sample of fat tissue in the subject's abdomen with a needle. Next, subjects will drink a sweet sugar solution for an Oral Glucose Tolerance Test (OGTT) and the research team will collect blood samples every 15 min for 3 hours. After this 3 hour test, the IV catheter will be removed and subjects will be provided breakfast and discharged.

Interventions

DIETARY_SUPPLEMENTOvereating Protocol

Subjects will ingest 30% more calories per day than their calculated daily energy requirements (\ 750kcals extra energy intake each day). All subjects will be instructed (and will be guided) to consume a diet containing approximately 50% carbohydrate, 35% fat, and 15% protein.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Age: 18-40 * Body Mass Index: 20-30 kg/m2 * Exercise group: (≥5 days/wk of aerobic exercise; 30-60min/session at moderate and vigorous intensities) * No Exercise group: no regularly planned exercise/physical activity * Women must have regularly occurring menses and must be premenopausal

Exclusion criteria

* Pregnant or lactating * Blood pressure \> 140/90 mm Hg * Evidence/history of cardiovascular or metabolic disease * Medications known to affect lipid or glucose metabolism * Tobacco or electronic cigarette user

Design outcomes

Primary

MeasureTime frameDescription
Oral Glucose Toleranceup to 1 weekAn index of insulin sensitivity will be measured using the plasma insulin and glucose concentrations during the 3h OGTT

Secondary

MeasureTime frameDescription
Resting Metabolic Ratebaseline and 1 week
Total Cholesterolbaseline and 1 weekPlasma concentrations of total- cholesterol will be measured
PPARg mRNA expressionbaseline and 1 weekcytokine proteins will be measured in adipose tissue

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026